nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—SLC12A1—appendage—muscle cancer	0.101	0.26	CbGeAlD
Methyclothiazide—SLC12A3—renal system—muscle cancer	0.0333	0.0855	CbGeAlD
Methyclothiazide—SLC12A1—renal system—muscle cancer	0.0255	0.0653	CbGeAlD
Methyclothiazide—Respiratory distress—Vincristine—muscle cancer	0.0225	0.037	CcSEcCtD
Methyclothiazide—CA1—renal system—muscle cancer	0.0175	0.0449	CbGeAlD
Methyclothiazide—SLC12A1—head—muscle cancer	0.017	0.0437	CbGeAlD
Methyclothiazide—SLC12A1—testis—muscle cancer	0.0165	0.0422	CbGeAlD
Methyclothiazide—Hyperuricaemia—Vincristine—muscle cancer	0.0154	0.0253	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Dactinomycin—muscle cancer	0.0151	0.0247	CcSEcCtD
Methyclothiazide—CA2—embryo—muscle cancer	0.015	0.0385	CbGeAlD
Methyclothiazide—Blood uric acid increased—Vincristine—muscle cancer	0.0146	0.0239	CcSEcCtD
Methyclothiazide—CA4—renal system—muscle cancer	0.0137	0.0351	CbGeAlD
Methyclothiazide—CA1—bone marrow—muscle cancer	0.0132	0.034	CbGeAlD
Methyclothiazide—Hyperuricaemia—Etoposide—muscle cancer	0.0125	0.0205	CcSEcCtD
Methyclothiazide—CA4—cardiac atrium—muscle cancer	0.0123	0.0314	CbGeAlD
Methyclothiazide—Blood uric acid increased—Etoposide—muscle cancer	0.0118	0.0194	CcSEcCtD
Methyclothiazide—CA2—smooth muscle tissue—muscle cancer	0.0118	0.0302	CbGeAlD
Methyclothiazide—CA1—head—muscle cancer	0.0117	0.0301	CbGeAlD
Methyclothiazide—CA2—renal system—muscle cancer	0.0114	0.0291	CbGeAlD
Methyclothiazide—CA4—tendon—muscle cancer	0.0107	0.0274	CbGeAlD
Methyclothiazide—CA4—bone marrow—muscle cancer	0.0104	0.0265	CbGeAlD
Methyclothiazide—CA2—cardiac atrium—muscle cancer	0.0102	0.0261	CbGeAlD
Methyclothiazide—CA4—head—muscle cancer	0.00916	0.0235	CbGeAlD
Methyclothiazide—Pneumonia—Dactinomycin—muscle cancer	0.00902	0.0148	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00889	0.0146	CcSEcCtD
Methyclothiazide—CA2—tendon—muscle cancer	0.00886	0.0227	CbGeAlD
Methyclothiazide—CA4—testis—muscle cancer	0.00885	0.0227	CbGeAlD
Methyclothiazide—Hypercalcaemia—Doxorubicin—muscle cancer	0.00866	0.0142	CcSEcCtD
Methyclothiazide—CA2—bone marrow—muscle cancer	0.00858	0.022	CbGeAlD
Methyclothiazide—Agranulocytosis—Dactinomycin—muscle cancer	0.00837	0.0137	CcSEcCtD
Methyclothiazide—CA2—vagina—muscle cancer	0.00822	0.0211	CbGeAlD
Methyclothiazide—Photosensitivity reaction—Vincristine—muscle cancer	0.0082	0.0134	CcSEcCtD
Methyclothiazide—Pneumonia—Vincristine—muscle cancer	0.00806	0.0132	CcSEcCtD
Methyclothiazide—Erythema multiforme—Dactinomycin—muscle cancer	0.00761	0.0125	CcSEcCtD
Methyclothiazide—CA2—head—muscle cancer	0.0076	0.0195	CbGeAlD
Methyclothiazide—Cramp muscle—Etoposide—muscle cancer	0.00758	0.0124	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Methotrexate—muscle cancer	0.00749	0.0123	CcSEcCtD
Methyclothiazide—Glycosuria—Doxorubicin—muscle cancer	0.00743	0.0122	CcSEcCtD
Methyclothiazide—CA2—testis—muscle cancer	0.00734	0.0188	CbGeAlD
Methyclothiazide—Vasculitis—Methotrexate—muscle cancer	0.00712	0.0117	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Methotrexate—muscle cancer	0.00708	0.0116	CcSEcCtD
Methyclothiazide—Pneumonia—Etoposide—muscle cancer	0.00653	0.0107	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Methotrexate—muscle cancer	0.00652	0.0107	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Doxorubicin—muscle cancer	0.00649	0.0106	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00643	0.0105	CcSEcCtD
Methyclothiazide—Jaundice—Etoposide—muscle cancer	0.00633	0.0104	CcSEcCtD
Methyclothiazide—Leukopenia—Dactinomycin—muscle cancer	0.00627	0.0103	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Methotrexate—muscle cancer	0.00619	0.0101	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Doxorubicin—muscle cancer	0.00613	0.01	CcSEcCtD
Methyclothiazide—Agranulocytosis—Etoposide—muscle cancer	0.00606	0.00993	CcSEcCtD
Methyclothiazide—Agitation—Vincristine—muscle cancer	0.00575	0.00943	CcSEcCtD
Methyclothiazide—Photosensitivity—Methotrexate—muscle cancer	0.00575	0.00942	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Doxorubicin—muscle cancer	0.00565	0.00926	CcSEcCtD
Methyclothiazide—Vertigo—Vincristine—muscle cancer	0.00563	0.00922	CcSEcCtD
Methyclothiazide—Leukopenia—Vincristine—muscle cancer	0.0056	0.00919	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Dactinomycin—muscle cancer	0.0056	0.00918	CcSEcCtD
Methyclothiazide—Erythema multiforme—Etoposide—muscle cancer	0.00551	0.00903	CcSEcCtD
Methyclothiazide—Anorexia—Dactinomycin—muscle cancer	0.00545	0.00894	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Doxorubicin—muscle cancer	0.00536	0.00878	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Vincristine—muscle cancer	0.00511	0.00838	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Vincristine—muscle cancer	0.005	0.0082	CcSEcCtD
Methyclothiazide—Photosensitivity—Doxorubicin—muscle cancer	0.00497	0.00815	CcSEcCtD
Methyclothiazide—Decreased appetite—Dactinomycin—muscle cancer	0.00497	0.00815	CcSEcCtD
Methyclothiazide—Vascular purpura—Doxorubicin—muscle cancer	0.00488	0.008	CcSEcCtD
Methyclothiazide—Muscle spasms—Etoposide—muscle cancer	0.00488	0.00799	CcSEcCtD
Methyclothiazide—Anorexia—Vincristine—muscle cancer	0.00487	0.00798	CcSEcCtD
Methyclothiazide—Paraesthesia—Vincristine—muscle cancer	0.00459	0.00752	CcSEcCtD
Methyclothiazide—Vertigo—Etoposide—muscle cancer	0.00456	0.00747	CcSEcCtD
Methyclothiazide—Leukopenia—Etoposide—muscle cancer	0.00454	0.00744	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—muscle cancer	0.00453	0.00743	CcSEcCtD
Methyclothiazide—Body temperature increased—Dactinomycin—muscle cancer	0.00452	0.00741	CcSEcCtD
Methyclothiazide—Decreased appetite—Vincristine—muscle cancer	0.00444	0.00728	CcSEcCtD
Methyclothiazide—Constipation—Vincristine—muscle cancer	0.00437	0.00716	CcSEcCtD
Methyclothiazide—Pancreatitis—Methotrexate—muscle cancer	0.00427	0.00701	CcSEcCtD
Methyclothiazide—Hypersensitivity—Dactinomycin—muscle cancer	0.00421	0.00691	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Etoposide—muscle cancer	0.00414	0.00679	CcSEcCtD
Methyclothiazide—Asthenia—Dactinomycin—muscle cancer	0.0041	0.00673	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Etoposide—muscle cancer	0.00405	0.00664	CcSEcCtD
Methyclothiazide—Body temperature increased—Vincristine—muscle cancer	0.00404	0.00662	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00399	0.00654	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Methotrexate—muscle cancer	0.00398	0.00652	CcSEcCtD
Methyclothiazide—Anorexia—Etoposide—muscle cancer	0.00395	0.00647	CcSEcCtD
Methyclothiazide—Diarrhoea—Dactinomycin—muscle cancer	0.00391	0.00641	CcSEcCtD
Methyclothiazide—Pneumonia—Methotrexate—muscle cancer	0.00391	0.00641	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00385	0.00632	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vincristine—muscle cancer	0.00376	0.00617	CcSEcCtD
Methyclothiazide—Paraesthesia—Etoposide—muscle cancer	0.00372	0.00609	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—muscle cancer	0.0037	0.00607	CcSEcCtD
Methyclothiazide—Asthenia—Vincristine—muscle cancer	0.00367	0.00601	CcSEcCtD
Methyclothiazide—Vomiting—Dactinomycin—muscle cancer	0.00364	0.00596	CcSEcCtD
Methyclothiazide—Agranulocytosis—Methotrexate—muscle cancer	0.00363	0.00595	CcSEcCtD
Methyclothiazide—Rash—Dactinomycin—muscle cancer	0.00361	0.00591	CcSEcCtD
Methyclothiazide—Decreased appetite—Etoposide—muscle cancer	0.0036	0.0059	CcSEcCtD
Methyclothiazide—Constipation—Etoposide—muscle cancer	0.00354	0.0058	CcSEcCtD
Methyclothiazide—Diarrhoea—Vincristine—muscle cancer	0.0035	0.00573	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00345	0.00565	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—muscle cancer	0.00341	0.00558	CcSEcCtD
Methyclothiazide—Nausea—Dactinomycin—muscle cancer	0.0034	0.00557	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—muscle cancer	0.00339	0.00555	CcSEcCtD
Methyclothiazide—Dizziness—Vincristine—muscle cancer	0.00338	0.00554	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00334	0.00547	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—muscle cancer	0.0033	0.00541	CcSEcCtD
Methyclothiazide—Urticaria—Etoposide—muscle cancer	0.00329	0.00539	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—muscle cancer	0.00328	0.00538	CcSEcCtD
Methyclothiazide—Body temperature increased—Etoposide—muscle cancer	0.00327	0.00536	CcSEcCtD
Methyclothiazide—Vomiting—Vincristine—muscle cancer	0.00325	0.00533	CcSEcCtD
Methyclothiazide—Rash—Vincristine—muscle cancer	0.00322	0.00528	CcSEcCtD
Methyclothiazide—Dermatitis—Vincristine—muscle cancer	0.00322	0.00528	CcSEcCtD
Methyclothiazide—Headache—Vincristine—muscle cancer	0.0032	0.00525	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—muscle cancer	0.00314	0.00515	CcSEcCtD
Methyclothiazide—Hypersensitivity—Etoposide—muscle cancer	0.00305	0.005	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—muscle cancer	0.00304	0.00498	CcSEcCtD
Methyclothiazide—Nausea—Vincristine—muscle cancer	0.00304	0.00498	CcSEcCtD
Methyclothiazide—Asthenia—Etoposide—muscle cancer	0.00297	0.00487	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—muscle cancer	0.00286	0.00469	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—muscle cancer	0.00286	0.00468	CcSEcCtD
Methyclothiazide—Diarrhoea—Etoposide—muscle cancer	0.00283	0.00464	CcSEcCtD
Methyclothiazide—Dizziness—Etoposide—muscle cancer	0.00274	0.00449	CcSEcCtD
Methyclothiazide—Vertigo—Methotrexate—muscle cancer	0.00273	0.00447	CcSEcCtD
Methyclothiazide—Leukopenia—Methotrexate—muscle cancer	0.00272	0.00446	CcSEcCtD
Methyclothiazide—Vomiting—Etoposide—muscle cancer	0.00263	0.00431	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—muscle cancer	0.00263	0.00431	CcSEcCtD
Methyclothiazide—Rash—Etoposide—muscle cancer	0.00261	0.00428	CcSEcCtD
Methyclothiazide—Dermatitis—Etoposide—muscle cancer	0.00261	0.00427	CcSEcCtD
Methyclothiazide—Headache—Etoposide—muscle cancer	0.00259	0.00425	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—muscle cancer	0.00253	0.00415	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Methotrexate—muscle cancer	0.00248	0.00406	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—muscle cancer	0.00248	0.00406	CcSEcCtD
Methyclothiazide—Nausea—Etoposide—muscle cancer	0.00246	0.00403	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Methotrexate—muscle cancer	0.00243	0.00398	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—muscle cancer	0.00242	0.00396	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—muscle cancer	0.00236	0.00387	CcSEcCtD
Methyclothiazide—Anorexia—Methotrexate—muscle cancer	0.00236	0.00387	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—muscle cancer	0.00235	0.00386	CcSEcCtD
Methyclothiazide—Paraesthesia—Methotrexate—muscle cancer	0.00223	0.00365	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—muscle cancer	0.00216	0.00353	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—muscle cancer	0.00215	0.00352	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Doxorubicin—muscle cancer	0.0021	0.00345	CcSEcCtD
Methyclothiazide—Anorexia—Doxorubicin—muscle cancer	0.00205	0.00335	CcSEcCtD
Methyclothiazide—Urticaria—Methotrexate—muscle cancer	0.00197	0.00323	CcSEcCtD
Methyclothiazide—Body temperature increased—Methotrexate—muscle cancer	0.00196	0.00321	CcSEcCtD
Methyclothiazide—Paraesthesia—Doxorubicin—muscle cancer	0.00193	0.00316	CcSEcCtD
Methyclothiazide—Decreased appetite—Doxorubicin—muscle cancer	0.00187	0.00306	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—muscle cancer	0.00184	0.00301	CcSEcCtD
Methyclothiazide—Hypersensitivity—Methotrexate—muscle cancer	0.00183	0.00299	CcSEcCtD
Methyclothiazide—Asthenia—Methotrexate—muscle cancer	0.00178	0.00292	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—muscle cancer	0.00171	0.0028	CcSEcCtD
Methyclothiazide—Body temperature increased—Doxorubicin—muscle cancer	0.0017	0.00278	CcSEcCtD
Methyclothiazide—Diarrhoea—Methotrexate—muscle cancer	0.0017	0.00278	CcSEcCtD
Methyclothiazide—Dizziness—Methotrexate—muscle cancer	0.00164	0.00269	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—muscle cancer	0.00158	0.00259	CcSEcCtD
Methyclothiazide—Vomiting—Methotrexate—muscle cancer	0.00158	0.00258	CcSEcCtD
Methyclothiazide—Rash—Methotrexate—muscle cancer	0.00156	0.00256	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—muscle cancer	0.00156	0.00256	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—muscle cancer	0.00155	0.00255	CcSEcCtD
Methyclothiazide—Asthenia—Doxorubicin—muscle cancer	0.00154	0.00253	CcSEcCtD
Methyclothiazide—Nausea—Methotrexate—muscle cancer	0.00147	0.00241	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—muscle cancer	0.00147	0.00241	CcSEcCtD
Methyclothiazide—Dizziness—Doxorubicin—muscle cancer	0.00142	0.00233	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—muscle cancer	0.00137	0.00224	CcSEcCtD
Methyclothiazide—Rash—Doxorubicin—muscle cancer	0.00135	0.00222	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—muscle cancer	0.00135	0.00222	CcSEcCtD
Methyclothiazide—Headache—Doxorubicin—muscle cancer	0.00134	0.0022	CcSEcCtD
Methyclothiazide—Nausea—Doxorubicin—muscle cancer	0.00128	0.00209	CcSEcCtD
